发明名称 ELECTROCARDIOGRAPHIC ASPECTS OF CHF TREATMENT
摘要 In accordance with the present invention, it has been found that prolonged QT-c intervals in mammalian patients, indicative of susceptibility of the patients to arrhythmia and sudden cardiac death, can be reduced by a process in which an aliquot of the patient's blood is removed and stressed extracorporeally, by application thereto of oxidative stress and electromagnetic radiation such as ultraviolet light, and then re-injected into the patient. Such treatment results in a significant reduction in QT-c interval in the patients, indicative of reduced susceptibility to arrhythmia and sudden cardiac death. In clinical trials described in the Examples section below, this reduction in QT-c interval was associated with a marked reduction in sudden cardiac death. There are also indications that, in the absence of treatment according to the invention, the patients would have exhibited a lengthening of their QT-c intervals.
申请公布号 KR20040108707(A) 申请公布日期 2004.12.24
申请号 KR20047016030 申请日期 2003.04.10
申请人 发明人
分类号 A61M1/36;A61K35/14;A61K41/00;A61N5/00;A61P9/04;A61P9/06 主分类号 A61M1/36
代理机构 代理人
主权项
地址